Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 32337590.
- Also identified by DOI 10.1093/cid/ciaa489 and PMC identifier 7197626.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We profiled the serological responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein and spike (S) glycoprotein. The majority of the patients developed robust antibody responses between 17 and 23 days after illness onset. Delayed, but stronger, antibody responses were observed in critical patients.
Medical subject headings
- Antibodies, Viral
- COVID-19
- Immunoglobulin G
- Immunoglobulin M